Archives: Agenda
Lessons learned when implementing AI effectively to enhance rare disease clinical trials
- Identifying where AI can enhance clinical trial processes for rare disease programs
- Overviewing common challenges when introducing AI to clinical processes
- Successfully implementing AI within teams to avoid delays and implementation challenges
Chairperson’s opening remarks
KEYNOTE PANEL: Designing clinical trials under regulatory volatility while staying in line with FDA expectations
- Understanding the current FDA regulatory landscape and its impact on rare diseases clinical development
- Identifying common regulatory pitfalls that delay approvals and strategies to mitigate them early
- Exploring innovative trial design that shorten timelines whilst keeping compliant with changing regulation
Moderator:
Panel seat reserved for event sponsor
Registration and refreshments
Afternoon refreshments and networking
NETWORKING DRINKS
T-cell immunotherapy: trends and insights shaping clinical development
• Overview of the T-cell immunotherapy landscape
• Trends in regulatory approvals and designations impacting trial timing and logistics
• Market outlook and projected growth through 2031 and the implications for supply planning
• Clinical trial insights, including leading countries and key challenges affecting trial execution
EXHIBITION APPLE PRIZE DRAW
Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!